Interventional cardiology continues to redefine how heart disease is treated, replacing open surgery with catheter-based precision.
Heart failure care has been rebuilt around four-pillar guideline-directed medical therapy, with new agents extending the toolkit across the LVEF spectrum.
Electrophysiology has been transformed by pulsed-field ablation, conduction-system pacing and AI-augmented rhythm detection.
Preventive cardiology now spans far beyond statins and aspirin.
As cancer survival improves, cardiovascular complications of anti-cancer therapy have become a defining specialty challenge.
Cardiac imaging has entered a phase of step-change resolution and AI-augmented interpretation.
Artificial intelligence and digital health are reshaping every step of the cardiology pathway.
Cardiometabolic medicine sits at the intersection of cardiology, endocrinology and nephrology — the CKM (cardiovascular-kidney-metabolic) syndrome framework now defines this shared territory.
Critical care cardiology has emerged as its own discipline, addressing the most complex cardiovascular emergencies.
Structural heart disease has matured from emerging specialty to mainstream pathway.
Pulmonary hypertension management has been transformed by sotatercept and a deeper understanding of pulmonary-vascular remodelling.
Cardiovascular genomics has moved from research curiosity to clinical decision tool.
The cardiomyopathy landscape has been redrawn in less than five years.
Hypertension remains the single largest contributor to cardiovascular mortality, yet only a minority of patients reach guideline targets.
Lipidology has moved well beyond statins.
Valvular heart disease management is increasingly transcatheter and increasingly personalised.
Heart rhythm disorders affect millions and present across every cardiovascular setting.
Coronary artery disease remains the largest single cardiovascular cause of mortality worldwide.
Sports cardiology addresses the cardiovascular care of athletes, active individuals and patients returning to exercise after disease.
Paediatric cardiology spans the foetus to the adolescent transitioning to adult care.
Geriatric cardiology focuses on the older patient — increasingly the typical cardiology patient.
Cardiac rehabilitation remains one of the most cost-effective interventions in cardiovascular care, yet referral and uptake lag the evidence.
Congenital heart disease care has been transformed by improved survival into adulthood.
Pericardial disease ranges from common acute pericarditis to rare constrictive and tumoral pathology.
Cardiovascular surgery continues to evolve alongside its transcatheter counterparts.
Vascular and aortic disease management now spans dedicated multidisciplinary teams.
Sudden cardiac arrest remains a leading cause of mortality worldwide and a defining acute cardiovascular emergency.
Echocardiography remains the workhorse of cardiac imaging, now augmented by 3D acquisition, strain analysis and AI interpretation.
Nuclear cardiology has been reinvigorated by PET, novel tracers and the diagnostic role in amyloidosis and inflammation.
Cardiovascular pharmacology drives the field forward.
Women's cardiovascular health addresses sex-specific phenotypes and persistent care disparities.
Inflammation is increasingly understood as a unifying mechanism in cardiovascular disease.
Rheumatic heart disease remains a major cardiovascular burden in low- and middle-income countries.
Cardiac nursing sits at the centre of safe, effective, person-centred cardiovascular care.
Global cardiovascular health addresses the largest gaps in cardiovascular medicine — the inequities between regions, races and resources.